NVSEF

Novartis Ag Basel Namen ... (PK) (NVSEF)

Novartis Ag Basel Namen Akt (PK)

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:NVSEF

1 2 3 4 5 6 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
10/06/2024	22h30	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
04/06/2024	22h30	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
31/05/2024	12h00	Edgar (US Regulatory)	Form SD - Specialized disclosure report	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
16/05/2024	22h31	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
13/05/2024	22h30	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
10/05/2024	22h31	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
08/05/2024	22h31	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
07/05/2024	22h45	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
06/05/2024	22h30	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
01/06/2020	14h53	Edgar (US Regulatory)	Specialized Disclosure Report (sd)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
12/05/2020	12h07	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
30/04/2020	22h12	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
30/04/2020	22h11	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
30/04/2020	22h09	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
30/04/2020	22h07	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
28/04/2020	13h59	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
02/04/2020	13h51	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
27/03/2020	15h16	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
27/03/2020	15h16	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
19/03/2020	11h06	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
02/03/2020	23h28	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
28/02/2020	14h30	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
14/02/2020	16h03	Edgar (US Regulatory)	Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
12/02/2020	21h35	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
11/02/2020	13h58	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
31/01/2020	12h08	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
30/01/2020	16h41	Edgar (US Regulatory)	Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (f-3asr)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
29/01/2020	15h14	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
29/01/2020	15h08	Edgar (US Regulatory)	Notice of Iran-related Disclosure Filed Pursuant to Section 13(r)(3) of the Exchange Act (irannotice)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)
29/01/2020	14h54	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	USOTC:NVSEF	Novartis Ag Basel Namen Akt (PK)